SCHEMBL6523698

SCHEMBL6523698

Cc1n[nH]c2c1c(=O)n(CCCO)c1ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
CDK4 P11802 6/20 0.43
CCND1 P24385 6/20 0.43
CCNE2 O96020 4/20 0.43
CCNE1 P24864 4/20 0.43
CDK2 P24941 4/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
PGR P06401 1/20 0.43
RORA P35398 1/20 0.43
RORC P51449 1/20 0.43
RORB Q92753 1/20 0.43
PIM3 Q86V86 3/20 0.43
PIM1 P11309 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
PKM P14618 1/20 0.42
PARP1 P09874 1/20 0.41
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6518602 0.93 AURKA (0.41) TSHRCDK4CCND1ALDH1A1HPGD
SCHEMBL6515436 0.88 CHEK1 (0.51) ALDH1A1HPGDPOLBPGRRORA
SCHEMBL6514910 0.85 CHEK1 (0.49) TSHRALDH1A1HPGDPOLBPGR
SCHEMBL21067780 0.83 CYP1A2 (0.48) ALDH1A1HPGDPGRKDM4ELMNA
SCHEMBL6508661 0.83 TOP2A (0.53) CDK4CCND1PIM3KDM4ETDP1
Hydrochloric Acid SCHEMBL6518743 0.82 TOP2A (0.52) CDK4CCND1PIM3KDM4EAURKA
SCHEMBL6510553 0.82 PLK1 (0.47) ALDH1A1POLBKDM4EPKMTDP1
SCHEMBL6514357 0.81 ALDH1A1 (0.44) ALDH1A1HPGDPOLBKDM4ELMNA
SCHEMBL6518571 0.81 HDAC3 (0.41) HPGDPOLBPGRRORARORC
SCHEMBL6508709 0.81 GAA (0.42) ALDH1A1HPGDPOLBPGRRORA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245563-A1 Chk-1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245563-A1 Chk-1 inhibitors CHKA, CHKB, CHEK1 TSHR 4004/4885CDK4 423/4885CCND1 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.